Smoking is Associated with a Higher Risk of Unplanned Medical Visits among Adult Patients with Diabetes

doi:10.21203/rs.2.14364/v1

Download PDF

Research article

Smoking is Associated with a Higher Risk of Unplanned Medical Visits among Adult Patients with Diabetes

https://doi.org/10.21203/rs.2.14364/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 06 May, 2020

Read the published version in BMC Health Services Research →

You are reading this older preprint version

Read the latest preprint version →

Background

Smoking exacerbates the complications of diabetes, but little is known about whether patients with diabetes have more unplanned medical visits. This study examines the association between smoking status and unplanned medical visits among patients with diabetes.

Methods

Data were drawn from electronic medical records (EMR’s) from a large healthcare provider in the Northern Plains region of the US, from adult (≥18 years old) patients with type 1 or type 2 diabetes who received care within this healthcare system at least once during the 3-year period spanning 2014-16 (N=62,149). The association between smoking status (current, former, or never smoker) and having ≥1 unplanned visit (comprised of emergency department visits, hospitalizations, hospital observations, and urgent care) was examined after adjusting for age, race/ethnicity, and body mass index (BMI). The top ten most common diagnoses for unplanned visits were examined by smoking status.

Results

Both current and former smoking were associated with an approximately 1.2-fold increase in the odds of having at least one unplanned medical visit in the 3-year period (OR=1.22, 95% CI=1.16-129; OR=1.23, 95% CI=1.19-1.28, respectively), relative to never-smokers. Most common diagnoses for all patients were pain-related. However, diagnoses related to musculoskeletal system and connective tissue disorders were more common among smokers. Smoking is associated with a higher rate of unplanned medical visits among patients with diabetes in this regional healthcare system.

Conclusions

Results from this study reveal higher rates of unplanned visits among smokers and former smokers, as well as increased frequencies of unplanned medical visits among current smokers.

Health Economics & Outcomes Research

Health Policy

Smoking

tobacco

diabetes

unplanned medical visits

In 2015, over 30.3 million persons in the United States or 9.4% of the population had diabetes, and about 1.5 million new cases were diagnosed every year among people 18 and over [1]. Both macrovascular and microvascular complications are more common in this population than in the general population. Infections including soft tissue, respiratory tract, and urinary tract infections are also more common among persons with diabetes [2]. As a result, Americans with diabetes in 2017 spent approximately $16,700 annually in health care costs, 2.3 times higher than those without diabetes [3]. Total costs of diabetes in 2017 were $327 billion annually, of which $237 billion were in direct medical costs [3].

Cigarette smoking is a well-established risk factor for complications of diabetes. Smoking decreases glycemic control [4], increases risk of infection [5], [6], and amplifies an already elevated risk of cardiovascular events [7], [8] Patients with diabetes are more likely to have unplanned medical visits [9], [10], but less is known about the impact of smoking on health care utilization and costs among patients with diabetes. A study following 206 patients with diabetic foot ulcers found 17% of patients had a 30-day unplanned readmission, noting current smoking and hypertension as independent predictors of readmission [11]. However, little research has looked at the association between smoking and unplanned medical visits more generally among this high-risk population.

Another issue adding to an already complex topic concerns the varied smoking regulatory environments individual states enact. The Congressional Budget Office [12] found that a 10% cigarette price increase will result in a 3-5% decrease in consumption, helping to improve public health. As of 2019, the average state cigarette tax is $1.70 per pack, with Washington DC having the highest tax ($4.50/pack) and Missouri having the lowest ($0.17/pack) [13]. Varying regulatory environments have the potential to impact smoking behaviors among individuals living in those states, an important variable to consider when examining smoking behaviors across state lines.

The primary objective of this retrospective study was to examine the relationship between smoking status and unplanned medical visits among patients with diabetes through electronic medical record (EMR) data from Sanford Health, a regional healthcare provider with a large patient base in Minnesota, North Dakota, and South Dakota. A sub-aim was to examine these relationships across different states with varied regulatory environments. The states represented in the study range broadly in their cigarette excise tax rates with North Dakota having the lowest taxes at $0.44 per pack (Rank 48^th) [14], Minnesota having one of the highest taxes at $3.04 (Rank 8^th)[15], and South Dakota in the middle ($1.53) with its ranking of 28^th[13], [16].

Sample

De-identified data were collected from existing EMR’s from Sanford Health, a non-for-profit rural healthcare provider that primarily serves the northern plains region of the U.S. Sanford Health includes 44 medical centers and 482 clinics with 1,382 physicians and 9,703 nurses delivering care in more than 80 specialty areas. A total of N=1,143,028 unique EMR’s were obtained from all patients who received care at a Sanford facility during the calendar years 2014–2016 (a 3-year period). For the study, those under 18 years of age were excluded (N=267,860), as were those whose most recent residential zip code was outside of Minnesota (MN), North Dakota (ND), or South Dakota (SD) (N=65,980) due to low sample sizes in other states. Records with missing data on smoking status were also excluded (N=34,742). Finally, the sample was restricted to those with a diagnosis of diabetes (ICD-10 codes E10.xx and E11.xx), for a final sample size of N=62,149.

Measures

Unplanned medical visits was derived from four separate variables for the numbers of 1) emergency department visits, 2) hospitalizations, 3) hospital observations, and 4) urgent care visits over the 3-year period. Two versions of the combined variable were created: a numeric variable representing the sum of all types of unplanned visits, and a binary variable indicating any (1+) or no (0) unplanned visits over the 3-year period.

Smoking status was obtained from EMR’s and was re-categorized as current smoking (collapsing the original levels of current every day smoker, current some day smoker, heavy tobacco smoker, light tobacco smoker, and smoker with current status unknown) vs. former smoking vs. never-smoking (collapsing the original levels of never smoker and passive smoke exposure).

Body mass index (BMI) was obtained from EMR’s. Extreme values of BMI < 15 or > 60 were assumed to be errors and were set to missing.

Race/ethnicity was collected from EMR’s in multiple variables for each race/ethnic group endorsed by the patient. For the current study, due to the predominantly white/Caucasian sample (87.9%), this was dichotomized as white (endorsed only white/Caucasian), vs. non-white (endorsed black/African American, American Indian/Alaska, Hispanic/Latino, Asian, Native Hawaiian/Pacific Islander, and/or multiracial).

Age and sex were also obtained from EMR’s.

Primary diagnoses for unplanned visits were available as ICD-10 codes for EMR’s from emergency department visits and urgent care visits over the 3-year period. ICD-codes were stripped to their prefix (e.g. “E11” instead of “E11.3”) to examine generally which conditions lead to unplanned medical visits, rather than focusing on highly specific diagnoses.

Analyses

First, unadjusted relationships between smoking status and unplanned medical visits were examined using chi-square tests (for any vs. no unplanned visits) and the non-parametric Kruskal-Wallis rank sum test (for the number of unplanned medical visits) due to the non-normality of the outcome variable.

Second, logistic regression was used to examine the odds of having an unplanned medical visit over the 3-year period as a function of smoking status while adjusting for age, sex, race/ethnicity, and BMI.

These analyses were performed separately by state (MN, ND, SD) in order to account for the different tobacco regulatory environments.

Finally, the 10 most common primary diagnoses from unplanned visits were tabulated within each smoking group for purposes of comparison.

Overall, 14.6% of the sample were current smokers, 39.5% were former smokers, and 45.9% had never smoked. Current smoking rates were similar across states, with a slightly higher prevalence in Minnesota (15.5%) than North Dakota (14.0%) or South Dakota (13.9%), and slightly more former smokers in Minnesota (41.6%) than in North Dakota (38.4%) or South Dakota (38.0%).

Descriptive statistics of patients with diabetes broken down by smoking status and state are shown in Table 1. Among the pooled sample, current smokers were most likely to have at least one unplanned medical visit over the 3-year period (59.1%), followed by former smokers (56.6%), with never-smokers having the lowest percentage (51.9%). Similarly, among patients with at least one unplanned medical visit over the 3-year period, current smokers (median: 3; interquartile range (IQR): 2–7) and former smokers (median: 3, IQR = 1–6) had a greater number of unplanned visits than never-smokers (median: 2, IQR: 1–5). Additionally, never-smokers were more likely to be white (91.1%) and less likely to be male (44.6%). However, trends in BMI and sex were non-monotonic across smoking categories: former smokers had the highest BMI (median: 32.4, interquartile range (IQR): 28.3-37.3) and the highest percentage of males (62.1%). All of these same trends held within each state (MN, ND, and SD).

The logistic regression (Table 2) showed that among patients with diabetes, both current and former smokers were more likely to have had at least 1 unplanned medical visit in the 3-year period (current smokers: OR=1.23, 95% confidence interval (CI) = 1.19–1.28; former smokers: OR=1.22, CI = 1.16–1.29) relative to never-smokers, after adjusting for white race, sex, and BMI. Follow-up analyses failed to find a significant difference between the odds of at least 1 unplanned medical visit between former smokers and current smokers (p=.698). Analyses by state (data not shown) were highly similar to the aggregate results shown in Table 2: both former and current smokers were significantly more likely to have had an unplanned medical visit in the 3-year period, relative to nonsmokers. Additionally, the odds of unplanned medical visits related to smoking status did not differ across state (MN, ND, or SD), judging by overlapping 95% confidence intervals; nor did ex-smokers differ from current smokers in terms of their odds of having an unplanned medical visit.

Table 3 shows the most common diagnoses from emergency department and urgent care visits during the 3-year period. Smokers and nonsmokers had a highly similar profile of diagnoses: the rank order of the five most common diagnoses was the same across the two groups, consisting mainly of pain-related diagnoses. However, most of these diagnoses were more common among smokers. Additionally, codes related to musculoskeletal system and connective tissue diagnoses tended to have a higher percentage among smokers in comparison to nonsmokers. Conversely, “pain in throat and chest” and “cough” more frequent among nonsmokers than among current or former smokers.

This paper utilizes regional EMR data to examine the relationship between smoking status and unplanned medical visits among patients with diabetes in ND, MN, and SD over a 3-year period. Results show that current and former smokers were more likely to have unplanned medical visits, which include emergency department, hospitalization, hospital observation, and urgent care visits. Further, among the diabetic patients who did have unplanned medical visits, current smokers had the greatest frequency of unplanned visits. The diagnoses from the unplanned emergency department and urgent care visits among smokers and non-smokers were similar and often related to pain (e.g. abdominal pain which may be due to uncontrolled glucose); however, smokers had a slightly higher proportion of visits related to connective tissue or musculoskeletal disorders compared to non-smokers.

Patients with diabetes generally have increased healthcare utilization compared to those without diabetes, including clinic visits, outpatient departments, and emergency departments [11], [17], [18]. The 2011 National Health Interview Survey revealed that 30% of diabetic patients had at least one emergency department visit within the last year, compared to only 20% of the general population [17]. While increased healthcare utilization is evident among diabetics, less research has focused on the impact of smoking among diabetics and its subsequent impact on healthcare utilization, specifically on unplanned medical visits. Our findings are novel in uncovering the increased likelihood of unplanned medical visits among smokers, delineating between former and current smokers as well as differences across states and their associated smoking regulations. Prior studies have suggested increased health resource utilization among diabetics who are also smokers [9], however these findings did not delineate among current and former smokers and the impact specifically on unplanned medical visits [10].

Our findings that smokers with diabetes had higher rates of musculoskeletal and connective tissue disorders is consistent with prior literature [19], [20]. Smoking has been found to heighten these complications given its effect on bone mineral density and adverse effects on joints [21], [22]. There has been early findings suggesting that smoking cessation can help regenerate lost bone and joint health, but reversing these complications takes extended time [21], which may explain the lack of statistical difference between current and former smokers in the present findings. Unfortunately, given nicotine’s therapeutic effects for chronic pain in smokers, smoking cessation may not be successful when pain persists and smoking provides a level of short-term alleviation [23]. Intervention efforts that focus on alleviation of pain associated with musculoskeletal and connective tissue disorders through other modalities may assist in removing a barrier to successful smoking cessation efforts.

Respiratory illnesses, in general, are common among diabetic patients [24]. Irregular insulin levels may influence known respiratory illness given the influx of blood glucose, harming vital tissue function [25]. Smokers, however, are less likely to seek treatment for respiratory illnesses such as cough than nonsmokers [26]. Complications in this regard for smokers lend to the notion that smokers seek tobacco as a potential treatment form in place of urgent care [27]. This could explain, in part, why the current study found that fewer current or former smokers reported respiratory complaints as compared to non-smokers.

Novel findings suggested differences by state in the prevalence of unplanned medical visits, with patients in Minnesota having the lowest rates of unplanned visits, followed by South Dakota, and finally North Dakota. This mirrors the tax rates associated with tobacco in each state, which is highest in Minnesota and lowest in North Dakota. Surprisingly, however, the smoking prevalence did not show the expected trends, with slightly more smokers in Minnesota ($3.04/pack) compared to North ($0.44/pack) and South Dakota ($1.53/pack). Nevertheless, there were no differences by state in the association between smoking and unplanned medical visits, meaning that smoking poses the same risk for unplanned medical visits despite differences in prevalence. In other words, once patients started smoking, they had similar risk for unplanned medical visits regardless of the tax environment. These findings highlight the importance of primary prevention of smoking in primary care settings, and the corresponding high-cost healthcare utilization.

Limitations

The observational nature of the data used in this study may be considered a limitation given no causal relationship between smoking and unplanned medical visits among diabetic patients can be inferred. Additionally, the findings related to most common diagnoses may not be representative, as diagnosis data were only available from urgent care visits and emergency department visits.

This study examines data from ND, MN and SD, and may be limited in its generalizability other populations. The sample is however relatively proportional to the patient population of the Northern Plains.

Strengths

It is well known that diabetic patients may have unplanned medical visits for other diabetes-related complications [28], [29] and few studies have shown higher rates of tobacco use among emergency department visits [29], [30]; however, exploring the relationship between diabetes and smoking in regards to unplanned visits is a novel concept. This study utilizes a very large sample size representative of the patient population in the Northern Plains, an important and often understudied region in the US.

Smoking may increase the rate of unplanned medical visits among patients with diabetes. While there is little literature examining the effects of smoking on healthcare utilization among diabetic patients, results from this study reveal higher rates of unplanned visits among smokers and former smokers, as well as increased frequencies of unplanned medical visits among current smokers. These findings add to the pervasive and well-established health risks of smoking [31]. Healthcare delivery settings represent a valuable opportunity for smoking cessation referrals, e.g. to existing state quit lines, which may especially benefit patients with diabetes in reducing costly healthcare utilization.

EMR: Electronic medical record

IQR: Inter-quartile range

OR: Odds ratio

CI: Confidence interval

BMI: Body mass index

MN: Minnesota

ND: North Dakota

SD: South Dakota

Ethics approval and consent to participate: Approval was obtained by Sanford Health Institutional Review Board and a waiver of informed consent was granted.

Consent for publication: N/A

Availability of data and materials: The de-identified datasets analyzed during the current study are available from the corresponding author on reasonable request.

Competing interests: The authors declare that they have no competing interests.

Funding: This work was supported by an award from the Sanford Data Collaborative, and by the National Institute for General Medical Sciences (NIGMS), grant number 1P20GM121341-01.

Author’s contributions: All authors qualify for inclusion based on BMC guidelines. AS, ELJ, EG, and BH conceived and designed the study and edited the manuscript. AS and DA carried out statistical analyses. TLW, JR, CS and DA drafted the manuscript. All authors read and approved the final manuscript.

[1] Centers for Disease Control and Prevention, “National Diabetes Statistics Report, 2017,” U.S. Department of Health and Human Services, Atlanta, GA, 2017.

[2] American Diabetes Association, “Standards of Care,” Diabetes Care, vol. 39 (Supplement 1): S1-S2, Jan. 2016.

[3] American Diabetes Association, “Economic Costs of Diabetes in the U.S. in 2017,” Diabetes Care, p. dci180007, Mar. 2018.

[4] M. Śliwińska-Mossoń and H. Milnerowicz, “The impact of smoking on the development of diabetes and its complications,” Diab. Vasc. Dis. Res., vol. 14, no. 4, pp. 265–276, 2017.

[5] S. E. Hofer et al., “International Comparison of Smoking and Metabolic Control in Patients With Type 1 Diabetes,” Diabetes Care, vol. 39, no. 10, pp. e177–e178, Oct. 2016.

[6] J. Casqueiro, J. Casqueiro, and C. Alves, “Infections in patients with diabetes mellitus: A review of pathogenesis,” Indian J. Endocrinol. Metab., vol. 16, no. Suppl1, pp. S27–S36, Mar. 2012.

[7] H. I. McDonald, D. Nitsch, E. R. C. Millett, A. Sinclair, and S. L. Thomas, “New estimates of the burden of acute community‐acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records,” p. 9, 2013.

[8] Pan An, Wang Yeli, Talaei Mohammad, and Hu Frank B., “Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus,” Circulation, vol. 132, no. 19, pp. 1795–1804, Nov. 2015.

[9] R. E. Washington, R. M. Andrews, and R. Mutter, “Emergency Department Visits for Adults with Diabetes, 2010: Statistical Brief #167,” in Healthcare Cost and Utilization Project (HCUP) Statistical Briefs, Rockville (MD): Agency for Healthcare Research and Quality (US), 2013.

[10] A. Sicras-Mainar, J. Rejas-Gutiérrez, R. Navarro-Artieda, and J. Ibánez-Nolla, “Effect of smoking status on healthcare costs and resource utilization in patients with type 2 diabetes in routine clinical practice: a retrospective nested case-control economic study,” Eur. Addict. Res., vol. 20, no. 2, pp. 94–104, 2014.

[11] C. M. Holscher, “Unplanned 30-day readmission in patients with diabetic foot wounds treated in a multidisciplinary setting,” J. Vasc. Surg., vol. 67, no. 3, p. 11, 2018.

[12] Congressional Budget Office, “Raising the Excise Tax on Cigarettes: Effects on Health and the Federal Budget,” Jun. 2012.

[13] Ann Boonn, “STATE CIGARETTE EXCISE TAX RATES & RANKINGS,” Campaign for Tobacco-Free Kids, 21-Dec-2018. [Online]. Available: https://www.tobaccofreekids.org/assets/factsheets/0097.pdf. [Accessed: 02-Apr-2019].

[14] North Dakota Office of State Tax Commisoner, “Tobacco Tax,” Cigarette and Tobacco Tax. [Online]. Available: http://www.nd.gov/tax/tobacco. [Accessed: 02-Apr-2019].

[15] Minnesota Department of Revenue, “Cigarette Tax,” Cigarette and Tobacco Taxes, 2018. [Online]. Available: https://www.revenue.state.mn.us/businesses/cigarette-tobacco/Pages/cigarette_tax.aspx. [Accessed: 03-Apr-2019].

[16] South Dakota Department of Revenue, “Information for Cigarette & Tobacco Retailers.” Division of Special Taxes, Apr-2017.

[17] J. S. Schiller, J. W. Lucas, B. W. Ward, and J. A. Peregoy, “Summary health statistics for U.S. adults: National Health Interview Survey, 2010,” Vital Health Stat. 10., no. 252, pp. 1–207, Jan. 2012.

[18] “National Ambulatory Medical Care Survey: 2010 Summary Tables.” U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics, 2010.

[19] L. H. Wyatt and R. J. Ferrance, “The musculoskeletal effects of diabetes mellitus,” J. Can. Chiropr. Assoc., vol. 50, no. 1, pp. 43–50, Mar. 2006.

[20] I. Douloumpakas, A. Pyrpasopoulou, A. Triantafyllou, C. Sampanis, and S. Aslanidis, “Prevalence of musculoskeletal disorders in patients with type 2 diabetes mellitus: a pilot study,” Hippokratia, vol. 11, no. 4, pp. 216–218, Oct. 2007.

[21] M. Abate, D. Vanni, A. Pantalone, and V. Salini, “Cigarette smoking and musculoskeletal disorders,” Muscles Ligaments Tendons J., vol. 3, no. 2, pp. 63–69, Apr. 2013.

[22] A. M. Al-Bashaireh, L. G. Haddad, M. Weaver, D. L. Kelly, X. Chengguo, and S. Yoon, “The Effect of Tobacco Smoking on Musculoskeletal Health: A Systematic Review,” J. Environ. Public Health, vol. 2018, p. 4184190, 2018.

[23] J. W. Ditre, J. D. Kosiba, E. L. Zale, M. J. Zvolensky, and S. A. Maisto, “Chronic Pain Status, Nicotine Withdrawal, and Expectancies for Smoking Cessation among Lighter Smokers,” Ann. Behav. Med. Publ. Soc. Behav. Med., vol. 50, no. 3, pp. 427–435, Jun. 2016.

[24] D. Pitocco et al., “The diabetic lung--a new target organ?,” Rev. Diabet. Stud. RDS, vol. 9, no. 1, pp. 23–35, 2012.

[25] D. Ardigo, S. Valtuena, I. Zavaroni, M. C. Baroni, and R. Delsignore, “Pulmonary complications in diabetes mellitus: the role of glycemic control,” Curr. Drug Targets Inflamm. Allergy, vol. 3, no. 4, pp. 455–458, Dec. 2004.

[26] C. Friedemann Smith, K. L. Whitaker, K. Winstanley, and J. Wardle, “Smokers are less likely than non-smokers to seek help for a lung cancer ‘alarm’ symptom,” Thorax, vol. 71, no. 7, pp. 659–661, Jul. 2016.

[27] J. W. Ditre and T. H. Brandon, “Pain as a Motivator of Smoking: Effects of Pain Induction on Smoking Urge and Behavior,” J. Abnorm. Psychol., vol. 117, no. 2, pp. 467–472, May 2008.

[28] J. W. Yan et al., “Risk factors for recurrent emergency department visits for hyperglycemia in patients with diabetes mellitus,” Int. J. Emerg. Med., vol. 10, Jul. 2017.

[29] P. M. Smith, “Tobacco Use among Emergency Department Patients,” Int. J. Environ. Res. Public. Health, vol. 8, no. 1, pp. 253–263, Jan. 2011.

[30] S. L. Bernstein and B. M. Becker, “Preventive care in the emergency department: diagnosis and management of smoking and smoking-related illness in the emergency department: a systematic review,” Acad. Emerg. Med. Off. J. Soc. Acad. Emerg. Med., vol. 9, no. 7, pp. 720–729, Jul. 2002.

[31] Centers for Disease Control and Prevention (US), National Center for Chronic Disease Prevention and Health Promotion (US), and Office on Smoking and Health (US), How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US), 2010.

Table 1: Descriptive statistics by smoking status.

	State	Never-Smoker N=28543	Former Smoker N=24550	Current Smoker N=9056	p
Any unplanned visits	MN	48.1% (4834)	53.7% (5223)	58.2% (2118)	<.001
	ND	55.7% (5586)	59.9% (4854)	59.8% (1770)	<.001
	SD	51.8% (4388)	57.0% (3823)	59.6% (1463)	<.001
	Total	51.9% (14808)	56.6% (13900)	59.1% (5351)	<.001
Number of unplanned visits	MN	2 (1 – 5)	3 (1 – 6)	3 (2 – 7)	<.001
	ND	2 (1 – 5)	3 (1 – 6)	3 (2 – 7)	<.001
	SD	2 (1 – 4)	3 (1 – 5)	3 (1 – 6)	<.001
	Total	2 (1 – 5)	3 (1 – 6)	3 (2 – 7)	<.001
BMI	MN	32.1 (28.0 – 37.1)	32.5 (28.4 – 37.3)	31.6 (27.1 – 36.8)	<.001
	ND	32.1 (28.1 – 37.2)	32.4 (28.3 – 37.3)	31.5 (27.2 – 36.6)	<.001
	SD	32.0 (27.8 – 37.3)	32.3 (28.2 – 37.2)	31.2 (26.8 – 36.5)	<.001
	Total	32.1 (28.0 – 37.2)	32.4 (28.3 – 37.3)	31.5 (27.1 – 36.7)	<.001
Non-Hispanic white	MN	91.0% (9017)	88.6% (8510)	69.8% (2507)	<.001
	ND	90.4 % (8925)	90.1% (7206)	81.3% (2375)	<.001
	SD	92.0%( 7753)	88.2% (5883)	74.2% (1810)	<.001
	Total	91.1% (25695)	89.0 (21599)	74.8 (6692)	<.001
Male	MN	43.6% (4379)	62.8% (6109)	53.2% (1938)	<.001
	ND	45.5% (4558)	62.7% (5085)	55.7% (1649)	<.001
	SD	44.9% (3805)	60.4% (4049)	52.3% (1282)	<.001
	Total	44.6% (12742)	62.1% (15243)	53.8% (4869)	<.001

Note: Categorical variables are presented as % (N) and numeric variables are presented as median (interquartile range). Significant differences by smoking status were tested with chi-square tests for categorical variables and Kruskal-Wallis rank sum tests for numeric variables. MN = Minnesota. ND = North Dakota. SD = South Dakota. BMI = body mass index.

Table 2: Logistic regression results of unplanned medical visits.

		OR	95% CI	p
Tobacco use	Never-smoker	(Ref)	(Ref)	(Ref)
	Former smoker	1.23	1.19 – 1.28	<.001
	Current smoker	1.22	1.16 – 1.29	<.001
BMI		1.00	(1.00 – 1.00)	.088
Race	White	(Ref)	(Ref)	(Ref)
Race	Non-white	1.73	(1.64 – 1.83)	<.001
Sex	Male	(Ref)	(Ref)	(Ref)
Sex	Female	1.20	(1.16 – 1.24)	<.001

Note: OR = odds ratio. CI = confidence interval. BMI = body mass index.

Table 3: Most common diagnoses from emergency room and urgent care visits, by smoking status.

Smokers with Diabetes		Nonsmokers with Diabetes
Diagnoses	Frequency	Diagnoses	Frequency
R10.xx: Abdominal and pelvic pain	6.6% (N = 4109)	R10.xx: Abdominal and pelvic pain	5.4% (N = 8856)
M54.xx: Dorsalgia	6.1% (N = 3750)	M54.xx: Dorsalgia	4.3% (N = 7099)
R07.xx: Pain in throat and chest	3.6% (N = 2252)	R07.xx: Pain in throat and chest	4.3% (N = 6971)
M25.xx: Other joint disorder, not elsewhere classified	3.4% (N = 2114)	M25.xx: Other joint disorder, not elsewhere classified	3.2% (N = 5175)
M79.xx: Other and unspecified tissue disorders	3.4% (N = 2085)	M79.xx: Other and unspecified tissue disorders	3.1% (N = 5092)
L03.xx: Cellulitis and acute lymphangitis	2.3% (N = 1453)	R05.xx: Cough	2.8% (N = 4547)
E11.xx: Type II Diabetes Mellitus	2.1% (N = 1314)	L03.xx: Cellulitis and acute lymphangitis	2.2% (N = 3526)
R05.xx: Cough	2.1% (N = 1298)	J40.xx: Bronchitis, not specified as acute or chronic	2.1% (N = 3422)
J40.xx: Bronchitis, not specified as acute or chronic	2.0% (N = 1265)	J02.xx: Acute pharyngitis	2.0% (N = 3222)
G43.xx: Migraine	1.9% (N = 1197)	R51.xx: Headache	1.8% (N = 3140)

Download PDF

Journal Publication

published 06 May, 2020

Read the published version in BMC Health Services Research →

Editorial decision: Major revision
25 Feb, 2020
Review #2 received at journal
14 Feb, 2020
Reviewer #2 agreed at journal
11 Feb, 2020
Review #1 received at journal
16 Dec, 2019
Reviewer #1 agreed at journal
11 Dec, 2019
Reviewers invited by journal
08 Oct, 2019
Submission checks completed at journal
09 Sep, 2019
Editor assigned by journal
04 Sep, 2019
First submitted to journal
03 Sep, 2019
Editor invited by journal
03 Sep, 2019

You are reading this older preprint version

Read the latest preprint version →

Smoking is Associated with a Higher Risk of Unplanned Medical Visits among Adult Patients with Diabetes

Status:

Journal Publication

Version 1

Abstract

Background

Methods

Results

Discussion

Conclusions

List of Abbreviations

Declarations

References

Tables

Status:

Journal Publication

Version 1